Clinical Trials Browser

Breast Neoplasms

Endometrial Neoplasms

Mouth Neoplasms, Oropharyngeal Neoplasms

Thyroid Neoplasms

Breast Neoplasms

Head and Neck Neoplasms, Postoperative Complications

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Head and Neck Neoplasms

Squamous Cell Carcinoma of Head and Neck

Phyllodes Tumor

Breast Neoplasms

Esophageal Neoplasms

Breast Neoplasms

Neoplastic Cells, Circulating

Uterine Cervical Neoplasms

Urinary Bladder Neoplasms

Neoplasms, Prostatic Neoplasms

Breast Cancer Radiotherapy

Esophageal Neoplasms

High-Risk Cancer

Breast Neoplasms, Phyllodes Tumor

Stomach Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Carcinoma, Squamous Cell, Esophageal Neoplasms, Lymphatic Metastasis

Prostatic Neoplasms

Esophageal Neoplasms

Laryngeal Diseases, Laryngeal Neoplasms, Neoplasms

Clinical Trials

EMERALD: Endocrine Therapy oMission With Radiation in ER+ Breast Cancer: Assessing Quality of Life and Disease Control: a Prospective Phase II Trial

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Adjuvant Radiotherapy for Stage II/III Thymoma After Complete Resection

Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma

RW Study of Adjuvant Radiotherapy in Locally Advanced Thyroid Cancer

Neoadjuvant SBRT Followed by Nab-Paclitaxel Combined With Toripalimab in HR+/HER2- Breast Cancer

POROMS

NICO

Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma

Effects of Radiotherapy in Borderline and Malignant Phyllodes Tumors After R0 Resection

Optimal Surgical Approach for Early-Stage Breast Cancer in Chinese Patients Aged ≤ 40 Years: a Cohort Study

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Neoadjuvant Radiotherapy for Breast Cancer

CETC

CERVANTES

CBPTMI

RAVES

Accelerated Hypofractionated 1 Week Radiotherapy in Breast Cancer Patients

Adjuvant Radiotherapy for Patients With Esophageal Squamous Cell Carcinoma After R0 Resection

Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder Cancer

Radiation Therapy After Surgery in Treating Women With Phyllodes Tumor of the Breast

Sorafenib, Epirubicin, Ifosfamide, and Radiation Therapy Followed By Surgery in Treating Patients With High-Risk Stage II or Stage III Soft Tissue Sarcoma

Adjuvant IMRT With Concommitant Raltitrexed Chemotherapy for Locally Advanced Gastric Cancer After D0/D1 Radical Resection

Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma

Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer

Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate Cancer

A Phase III Trail of Adjuvant Chemoradiotherapy Versus Adjuvant Radiotherapy in Esophageal Squamous Cell Carcinoma

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers